LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage

Neurological Research

Volumn 38, Issue 10, 2016, Pages 903-908

  You, Shoujiang ^a   Zhong, Chongke ^b   Xu, Jiaping ^a   Han, Qiao ^c   Zhang, Xia ^a   Liu, Huihui ^a   Zhang, Yanlin ^a   Shi, Jijun ^a   Huang, Zhichao ^a   Xiao, Guodong ^a   Zhang, Chunyuan ^a   Cao, Yongjun ^a,d   Liu, Chunfeng ^a,d  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c The hospital of traditional Chinese medicine   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Intracranial hemorrhage; Low density lipoprotein cholesterol; Low density lipoprotein cholesterol high density lipoprotein cholesterol (LDL C HDL C) ratio; Mortality

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN HEMORRHAGE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT; COMPUTED TOMOGRAPHY SCANNER; DIAGNOSTIC IMAGING; FOLLOW UP; METABOLISM; NONPARAMETRIC TEST; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; STATISTICS, NONPARAMETRIC; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; YOUNG ADULT;

EID: 84978538761     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1080/01616412.2016.1204797     Document Type: Article

References (28)

1. C.E.Lovelock, A.J.Molyneux, P.M.Rothwell. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006:a population-based study. Lancet Neurol. 2007;6:487–3.10.1016/S1474-4422(07)70107-2
2. V.L.Feigin, C.M.Lawes, D.A.Bennett, S.L.Barker-Collo, V.Parag. Worldwide stroke incidence and early case fatality reported in 56 population-based studies:a systematic review. Lancet Neurol. 2009;8:355–69.10.1016/S1474-4422(09)70025-0
3. J.F.Meschia, C.Bushnell, B.Boden-Albala, L.T.Braun, D.M.Bravata, S.Chaturvedi,. Guidelines for the primary prevention of stroke:a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754–832. 10.1161/STR.0000000000000046
4. W.N.Kernan, B.Ovbiagele, H.R.Black, D.M.Bravata, M.I.Chimowitz, M.D.Ezekowitz,. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–236. doi:10.1161/STR.0000000000000024.
5. H.Iso, D.R.Jacobs, Jr, D.Wentworth, J.D.Neaton, J.D.Cohen. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904–10.10.1056/NEJM198904063201405
6. J.D.Sturgeon, A.R.Folsom, W.T.Longstreth, Jr, E.Shahar, W.D.Rosamond, M.Cushman. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38:2718–25.10.1161/STROKEAHA.107.487090
7. D.L.Tirschwell, N.L.Smith, S.R.Heckbert, R.N.Lemaitre, W.T.Longstreth, Jr, B.M.Psaty. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology. 2004;63:1868–75.10.1212/01.WNL.0000144282.42222.DA
8. H.Tanaka, Y.Ueda, M.Hayashi, C.Date, T.Baba, H.Yamashita,. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke. 1982;13:62–73. doi:10.1161/01.STR.13.1.62.
9. X.Wang, Y.Dong, X.Qi, C.Huang, L.Hou. Cholesterol levels and risk of hemorrhagic stroke:a systematic review and meta-analysis. Stroke. 2013;44:1833–9.10.1161/STROKEAHA.113.001326
10. J.Roquer, C.A.Rodriguez, M.Gomis, A.Ois, E.Munteis, P.Bohm. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology. 2005;65:1198–202.10.1212/01.wnl.0000180968.26242.4a
11. J.M.Ramirez-Moreno, I.Casado-Naranjo, J.C.Portilla, M.L.Calle, D.Tena, A.Falcón,. Serum Cholesterol LDL and 90 day mortality in patients with intracerebral hemorrhage. Stroke. 2009;40:1917–20. doi:10.1161/STROKEAHA.108.536698.
12. D.Rodriguez-Luna, M.Rubiera, M.Ribo, P.Coscojuela, J.Pagola, S.Piñeiro,. Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage. Stroke. 2011;42:2447–52. doi:10.1161/STROKEAHA.110.609461.
13. W.B.Kannel. Risk stratification of dyslipidemia:insights from the Framingham Study. Curr Med Chem Cardiovasc Hematol Agents. 2005;3:187–93.10.2174/1568016054368250
14. C.J.Packard, I.Ford, M.Robertson, J.Shepherd, G.J.Blauw, M.B.Murphy,. Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the prospective study of pravastatin in the elderly at risk (PROSPER). Circulation. 2005;112:3058–65. doi:10.1161/CIRCULATIONAHA.104.526848.
15. R.U.Kothari, T.Brott, J.P.Broderick, W.G.Barsan, L.R.Sauerbeck, M.Zuccarello,. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304–5. doi:10.1161/01.STR.27.8.1304.
16. I.B.Puddey. Low serum cholesterol and the risk of cerebral haemorrhage. Atherosclerosis. 1996;119:1–6.10.1016/0021-9150(95)05634-3
17. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998; 352:1801–7.
18. M.D.Vergouwen, M.Vermeulen, Y.B.Roos. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology 2009; 72:1447; author reply 1447–8.10.1212/01.wnl.0000346744.56398.e5
19. D.G.Hackam, P.C.Austin, A.Huang, D.N.Juurlink, M.M.Mamdani, J.M.Paterson,. Statins and intracerebral hemorrhage:a retrospective cohort study. Arch Neurol. 2012;69:39–45. doi:10.1001/archneurol.2011.228.
20. D.G.Hackam, M.Woodward, L.K.Newby, D.L.Bhatt, M.Shao, E.E.Smith,. Statins and intracerebral hemorrhage:collaborative systematic review and meta-analysis. Circulation. 2011;124:2233–42. doi:10.1161/CIRCULATIONAHA.111.055269.
21. V.Manninen, L.Tenkanen, P.Koskinen, J.K.Huttunen, M.Mänttäri, O.P.Heinonen,. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85:37–45.
22. T.Kimura, T.Itoh, T.Fusazaki, H.Matsui, S.Sugawara, Y.Ogino,. Low-density lipoprotein-cholesterol/high-density lipoprotein-cholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease–integrated-backscatter intravascular ultrasound study. Circ J. 2010;74:1392–8. doi:10.1253/circj.CJ-09-0849.
23. O.Y.Bang, J.L.Saver, D.S.Liebeskind, S.Starkman, P.Villablanca, N.Salamon,. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology. 2007;68:737–42. doi:10.1212/01.wnl.0000252799.64165.d5.
24. G.Ooneda, Y.Yoshida, K.Suzuki, H.Shinkai, S.Hori, K.Kobori,. Smooth muscle cells in the development of plasmatic arterionecrosis, arteriosclerosis, and arterial contraction. Blood Vessels. 1978;15:148–56.
25. N.Tandon, J.T.Harmon, D.Rodbard, G.A.Jamieson. Thrombin receptors define responsiveness of cholesterol-modified platelets. J Biol Chem. 1983;258:11840–5.
26. H.C.O’Donnell, J.Rosand, K.A.Knudsen, K.L.Furie, A.Z.Segal, R.I.Chiu,. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000;342:240–5. doi:10.1056/NEJM200001273420403.
27. C.Tzourio, H.Arima, S.Harrap, C.Anderson, O.Godin, M.Woodward,. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology. 2008;70:1322–8. doi:10.1212/01.wnl.0000308819.43401.87.
28. M.R.Raffeld, A.Biffi, T.W.Battey, A.M.Ayres, A.Viswanathan, S.M.Greenberg,. APOE epsilon4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage. Neurology. 2015;85:349–56. doi:10.1212/WNL.0000000000001790.